首页> 美国卫生研究院文献>Journal of Clinical Medicine >Microaneurysm Turnover in Mild Non-Proliferative Diabetic Retinopathy is Associated with Progression and Development of Vision-Threatening Complications: A 5-Year Longitudinal Study
【2h】

Microaneurysm Turnover in Mild Non-Proliferative Diabetic Retinopathy is Associated with Progression and Development of Vision-Threatening Complications: A 5-Year Longitudinal Study

机译:轻度不增殖糖尿病视网膜病变的微安肌瘤周转与视力威胁并发症的进展和发展有关:5年纵向研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Analysis of retinal microaneurysm turnover (MAT) has been previously shown to contribute to the identification of eyes at risk of developing clinically significant complications associated with diabetic retinopathy (DR). We propose to further characterize MAT as a predictive biomarker of DR progression and development of vision-threatening complications. Methods: 212 individuals with type 2 diabetes (T2D; ETDRS grades 20 and 35) were evaluated annually in a 5-year prospective, longitudinal study, by color fundus photography and optical coherence tomography. Endpoints were diabetic macular edema (DME) or proliferative retinopathy (PDR). MAT analysis included determination of MA formation and disappearance rates, automatically assessed using the RetMarkerDR®. Retinopathy severity progression was evaluated using step increases in ETDRS severity levels. Results: Of the 212 individuals, 172 completed the 5-year follow-up study or developed an endpoint (n = 27). MAT calculated at 1 year showed a significant difference between groups of endpoint developments (p = 0.018), particularly MA disappearance rate (p = 0.007). MAT also showed a significant difference between eyes with different ETDRS severity progression in the 5-year period (p = 0.035). Conclusions: MAT is an indicator of the development of DME and/or PDR as well as of DR severity progression in T2D individuals with mild retinopathy.
机译:背景:预先证明了视网膜微型肌肉胞质胞质转换(MAT)的分析,以有助于鉴定眼睛,有可能在患有糖尿病视网膜病变(DR)相关的临床显着并发症的风险。我们建议进一步表征垫作为博士进展和视力威胁并发症的发展的预测生物标志物。方法:每年在5年的前瞻性,纵向研究中每年进行212名糖尿病(T2D; ETDRS等级20和35级),通过彩色眼底摄影和光学相干断层扫描。终点是糖尿病黄斑水肿(DME)或增殖视网膜病变(PDR)。垫分析包括MA形成和消失率的测定,使用RetMarkerDR®自动评估。使用ETDRS严重程度的步骤增加评估视网膜病变严重性进展。结果:212个个体,172人完成了5年的后续研究或开发了一个终点(n = 27)。在1年内计算的垫在终点开发组(P = 0.018)之间显示出显着差异(P = 0.018),特别是MA消失率(P = 0.007)。席克在5年期间,在不同的ETDRS严重进展中,眼睛之间也显示出显着差异(P = 0.035)。结论:MAT是在T2D个体患有轻度视网膜病变DME和/或PDR的以及DR严重性进展的发展的指标。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号